Net Good IndexSubmit a correction

Benefit Ledger · provisional · Medicine & Health

STAT+: GSK touts lung cancer data from two drugs

Late-stage results for Definium's LSD treatment, AstraZeneca breast cancer drug fails key trial, and more biotech news from The Readout

Tier 1 UsefulMethodology 0.2
Submit a correction

Current score

+0.00

1 base · Useful (tier 1 of 5, 1 pts)
× 0.1000 attribution · Minor documented assistance
× 0.4000 evidence · External expert evaluation
× 0.2000 realization · Proposed
× 0.5000 durability · Medium-term
Event-level product before credit split: 0.00

Ingest update: independent source raised evidence; added a follow-up source. Score remains provisional until review. Follow-up ingest: independent source raised evidence; added a follow-up source. Follow-up ingest: independent source raised evidence; added a follow-up source.

What happened

Late-stage results for Definium's LSD treatment, AstraZeneca breast cancer drug fails key trial, and more biotech news from The Readout Update (2026-09-17): STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal. A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of the U.S.-U.K. pharma pact. Update (2026-09-17): STAT+: New startup to test psychedelic-like drug against Parkinson’s symptom. A psychedelic-like drug for a Parkinson's symptom, mice with half-human brains, and more biotech news in the Readout newsletter. Update (2026-09-25): OpenAI lawsuit, MCAS test results, Last Ditch bar - New England Public Media. OpenAI lawsuit, MCAS test results, Last Ditch bar  New England Public Media

Model attribution

Unspecified AI system
Version unspecified
+0.00

Unspecified

Unspecified system mentioned or implied by a news item. Remap to a named release when identified.

News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.

Attribution 0.1000 · Credit share 100% · Unknown

Claims

  • STAT+: GSK touts lung cancer data from two drugs

    outcome · supported

Sources

primary sources

independent sources

other sources

Revision history

  • 14 Sep 2026 · 0.00 → 0.00

    Auto-published from news ingest.

  • 17 Sep 2026 · 0.00 → 0.00

    Ingest update: independent source raised evidence; added a follow-up source.

  • 17 Sep 2026 · 0.00 → 0.00

    Ingest update: independent source raised evidence; added a follow-up source.

  • 26 Sep 2026 · 0.00 → 0.00

    Ingest update: independent source raised evidence; added a follow-up source.

Submit a correction